RMIT University
Browse

Prevalence of excessive daytime sleepiness in a sample of the Australian adult population

journal contribution
posted on 2024-11-02, 01:39 authored by Amie Hayley, Lana Williams, Gerard KennedyGerard Kennedy, Michael Berk, Sharon Brennan, Julie Pascoe
Objectives: Excessive daytime sleepiness (EDS) is associated with significant personal and medical burden. However, there is little indication of the impact of these symptoms in the broader population. Participants and methods: We studied 946 men ages 24-92. years (median age, 59.4 [interquartile range {IQR}, 45-73. years]) and 1104 women ages 20-94. years (median age, 50 [IQR, 34-65. years]) who resided in the Barwon Statistical Division, South-Eastern Australia, and participated in the Geelong Osteoporosis Study (GOS) between the years of 2001 and 2008. EDS was defined as an Epworth Sleepiness Scale (ESS) score of ≥10. Lifestyle factors, history of medical conditions, and medication history were documented by self-report. Results: For men, the age-specific prevalence of EDS was 5.1% (ages 20-29. years), 6.4% (ages 30-39. years), 9.8% (ages 40-49. years), 15.5% (ages 50-59. years), 12.0% (ages 60-69. years), 12.0% (ages 70-79. years), and 29.0% (ages ≥80. years). For women, the age-specific prevalence of EDS was 14.7% (ages 20-29. years), 8.7% (ages 30-39. years), 15.0% (ages 40-49. years), 16.0% (ages 50-59. years), 12.6% (ages 60-69. years), 13.2% (ages 70-79. years), and 17.0% (ages ≥80. years). Overall standardized prevalence of EDS was 10.4% (95% confidence interval, 9.7-11.2) for men and 13.6% (95% confidence interval, 12.8-14.4) for women. Conclusions: The prevalence of EDS increased with age, affecting approximately one-third of those aged ≥80. years. Because EDS has been associated with poorer health outcomes in the older age strata, these findings suggest that routine screening may be beneficial in ongoing health assessments for these individuals. Overall, more than one-tenth of the Australian adult population has EDS, which is indicative of possible underlying sleep pathology.

Funding

Novel therapies, risk pathways and prevention of mood disorders

National Health and Medical Research Council

Find out more...

History

Journal

Sleep Medicine

Volume

15

Issue

3

Start page

348

End page

354

Total pages

7

Publisher

Elsevier

Place published

Netherlands

Language

English

Copyright

© 2014 Elsevier B.V.

Former Identifier

2006066834

Esploro creation date

2020-06-22

Fedora creation date

2016-09-28

Usage metrics

    Scholarly Works

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC